abstract |
The present invention relates to pharmaceutical compositions for liver protection comprising keratin, PEGylated keratin or PEGylated keratin nanoparticles and pharmaceutical compositions for the prevention or treatment of hepatotoxic diseases. The keratin, PEGylated keratin, or PEGylated keratin nanoparticles have little or no toxicity, remarkably elevate the expression of UGT1A1 and related receptors, and have hepatocyte protective action and hepatotoxicity inhibiting action. Therefore, Can be effectively used as a composition for preventing or treating cancer. |